3,4-dihydroxyphenylglycol has been researched along with oxidopamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biziere, K; Gonon, F; Mermet, C; Steinberg, R; Suaud-Chagny, MF | 1 |
| Soares-da-Silva, P | 1 |
| Baklaushev, VP; Chekhonin, VP; Dmitrieva, TB; Filatova, TS; Kogan, BM; Lebedev, SV; Man'kovskaya, IV; Savchenko, EA; Yusupova, IU | 1 |
| Ding, JH; Hu, G; Li, H | 1 |
| Albin, RL; Feeley Kearney, JA | 1 |
| Bernardi, G; Berretta, N; de Castro, D; Freestone, PS; Geracitano, R; Guatteo, E; Lipski, J; Mercuri, NB | 1 |
| Agari, T; Borlongan, CV; Date, I; Kondo, A; Kuramoto, S; Matsui, T; Miyoshi, Y; Shingo, T; Yasuhara, T | 1 |
7 other study(ies) available for 3,4-dihydroxyphenylglycol and oxidopamine
| Article | Year |
|---|---|
In vivo voltammetric monitoring of catecholamine metabolism in the A1 and A2 regions of the rat medulla oblongata.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Catecholamines; Clonidine; Dopamine; Electrochemistry; Hydroxydopamines; Kinetics; Male; Medulla Oblongata; Methoxyhydroxyphenylglycol; Methyltyrosines; Norepinephrine; Oxidopamine; Pargyline; Rats; Tissue Distribution | 1986 |
Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Droxidopa; Heart Ventricles; Jejunum; Kidney; Kidney Cortex; Liver; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Oxidopamine; Rats; Rats, Wistar | 1993 |
Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar | 2000 |
Group I mGluR ligands fail to affect 6-hydroxydopamine- induced death and glutamate release of PC12 cells.
Topics: Adrenergic Agents; Alanine; Animals; Apoptosis; Cell Survival; DNA Fragmentation; Drug Interactions; Glutamic Acid; Ligands; Methoxyhydroxyphenylglycol; Oxidopamine; PC12 Cells; Rats; Receptors, Metabotropic Glutamate | 2003 |
mGluRs: a target for pharmacotherapy in Parkinson disease.
Topics: Amino Acids, Dicarboxylic; Animals; Autoradiography; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glucose; Immunohistochemistry; Methoxyhydroxyphenylglycol; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Receptors, Metabotropic Glutamate | 2003 |
Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro.
Topics: Action Potentials; Animals; Dendrites; Dopamine; Dopamine Plasma Membrane Transport Proteins; Electrophysiology; Fluorescent Dyes; In Vitro Techniques; Isoquinolines; Membrane Potentials; Methoxyhydroxyphenylglycol; Neurons; Oxidopamine; Patch-Clamp Techniques; Rats; Rats, Wistar; Rhodamines; Spectrometry, Fluorescence; Substantia Nigra | 2005 |
Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Dioxolanes; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Methoxyhydroxyphenylglycol; Motor Activity; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Purines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2008 |